| Malignant Bile Duct Neoplasm studied in …STUDIED_INderived200 of 883show all (up to 200) |
|---|
| → studied in | NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766187Phase 2 · not yet recruiting Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07846267Phase 2 · not yet recruiting Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847710Phase 2 · recruiting Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645160Phase 1/Phase 2 · recruiting Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910670NA · active not recruiting Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673341Phase 2 · recruiting [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841574Phase 2 · recruiting HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Malignant Extrahepatic Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06302621Phase 1 · recruiting Pemigatinib + Afatinib in Advanced Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06888063Phase 2 · recruiting Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836777Phase 2 · not yet recruiting Efficacy and Safety of MitoQ in Improving Cancer Cachexia · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07146646Phase 2 · recruiting Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213791Phase 1 · recruiting A Study of LY4337713 in Participants With FAP-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522476Phase 2 · recruiting A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375915Phase 2 · recruiting Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02381561Phase 1 · active not recruiting Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708067Phase 1 · active not recruiting Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814586not yet recruiting Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161869recruiting Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780838Phase 2 · recruiting Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Extrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212274Phase 2 · active not recruiting Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039892Phase 2 · not yet recruiting Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Adult Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037980Phase 2/Phase 3 · recruiting CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175845NA · recruiting Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01915225recruiting Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050252Phase 2 · suspended Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07120295Phase 4 · recruiting Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286814Phase 2 · recruiting PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05506943Phase 2/Phase 3 · active not recruiting A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06728410Phase 2 · recruiting A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05727176Phase 2 · recruiting Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796997Phase 1 · not yet recruiting GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Distal Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497531NA · recruiting Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07632235Phase 1/Phase 2 · not yet recruiting A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793253Phase 2 · not yet recruiting Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737692NA · completed Effects of Aerobic and Resistance Exercise Training in Individuals With Cancer Cachexia · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510740active not recruiting Liver Cancer Registry Platform · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923475Phase 2/Phase 3 · recruiting Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Extrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068194Phase 1/Phase 2 · active not recruiting Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06453590NA · active not recruiting Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619313Phase 1 · recruiting AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07043387recruiting Streamlining Radioembolization for CCC and Metastatic Liver Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891289Phase 2 · recruiting Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05791448Phase 1 · suspended AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06048133Phase 2 · active not recruiting Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768085NA · not yet recruiting Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07765433Phase 2/Phase 3 · not yet recruiting Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Extrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06840886Phase 1 · recruiting A Study of PHST001 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07260175Phase 2 · recruiting Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07760038NA · recruiting Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03656536Phase 3 · terminated A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06899152NA · recruiting HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07486713Phase 4 · recruiting Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594067Phase 1 · recruiting TCR1188-ABC Cells in KRAS-mutated Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06160752Phase 1 · active not recruiting Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07653594NA · not yet recruiting TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564403Phase 2 · active not recruiting Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744087NA · recruiting Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Distal Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878095Phase 2 · active not recruiting Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05285358Phase 1 · recruiting Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Distal Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06877637recruiting On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05876754Phase 3 · active not recruiting An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607302recruiting Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07738939Phase 1 · not yet recruiting IKS04 Regimen in Advanced Solid Tumors That Express CA242 · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563870NA · completed Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06506955Phase 2/Phase 3 · active not recruiting Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07729917Phase 2 · not yet recruiting Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04521686Phase 1 · active not recruiting Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06192797Phase 2 · recruiting Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07716345not yet recruiting Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer · condition mapped PROBABILISTIC · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990659NA · recruiting Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707661not yet recruiting Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422690Phase 2 · recruiting The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704021completed Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704203not yet recruiting Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704216not yet recruiting Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer · condition mapped PROBABILISTIC · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06340646NA · recruiting Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691515Phase 3 · not yet recruiting Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200042Phase 3 · terminated Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05000294Phase 1/Phase 2 · recruiting Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05277766Phase 1 · active not recruiting Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451849Phase 1/Phase 2 · terminated A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05874414Phase 1/Phase 2 · recruiting Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942328Phase 1/Phase 2 · recruiting Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06342414recruiting An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224750recruiting A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05948475Phase 3 · active not recruiting Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088775NA · completed PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Extrahepatic Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05724563Phase 2 · active not recruiting Domvanalimab and Zimberelimab in Advanced Liver Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06101277NA · recruiting Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06260943NA · recruiting Targeted Navigation in Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169734Phase 1/Phase 2 · recruiting A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01862315Phase 2 · completed Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658586active not recruiting AI Multimodal Model for Liver Cancer Diagnosis and Prognosis · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04251715Phase 2 · terminated mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05185947Phase 2 · completed Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01715402completed Optimization of Health Expenditure in Liver Surgery · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03872947Phase 1 · active not recruiting A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03991832Phase 2 · active not recruiting Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626312Phase 1 · terminated Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925516Phase 2 · recruiting A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07558304NA · not yet recruiting Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646717Phase 2 · active not recruiting Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641036Phase 1/Phase 2 · recruiting Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07640048recruiting Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623642Phase 2 · not yet recruiting A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566393available Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379377Phase 1 · active not recruiting 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619937Phase 2 · completed Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620080NA · not yet recruiting EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621536completed Diagnostic Accuracy of Eus Fnb in Difficult to Reach Lesions · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257761Phase 1 · active not recruiting Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Extrahepatic Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801083Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02757859NA · active not recruiting WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06851663Phase 2/Phase 3 · recruiting Trop2-targeted immunoPET Imaging of Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07613125NA · active not recruiting The Effect of Locally Made Nutritional Supplementation on Cancer Cachexia in Bangladesh: A Quasi-experimental Study. · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614061Phase 1 · recruiting Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504604NA · recruiting TCF-001 TRACK (Target Rare Cancer Knowledge) Study · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05546372NA · recruiting Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05874934NA · completed Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06274879Phase 2 · recruiting Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04572711completed Prospective Evaluation of Biliary Tissue Sampling With ERCP · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07598318Phase 2/Phase 3 · not yet recruiting Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503146Phase 2 · recruiting 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04421820Phase 1/Phase 2 · recruiting BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04042831Phase 2 · active not recruiting Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Bile Duct Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07557225NA · recruiting 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058663Phase 1 · recruiting Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735560NA · recruiting Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441747Phase 2 · recruiting Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570849Phase 2 · recruiting Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07030140Phase 2 · recruiting Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561775Phase 2 · not yet recruiting Adebrelimab Plus S-1 for Resected Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07478523Phase 2 · recruiting FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07206355recruiting In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07556835not yet recruiting Outcomes After Liver and Biliary Resection at a High-Volume Center · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06723236Phase 1 · recruiting A Study of MGC028 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05655949Phase 2 · recruiting Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05179486recruiting Molecular Epidemiology of Biliary Tree Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06777316Phase 1/Phase 2 · active not recruiting A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05967182Phase 2 · recruiting A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476651NA · recruiting Scout Dose of Resin Microspheres · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02872831NA · withdrawn Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04834674Phase 2 · completed DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514533Phase 2 · not yet recruiting The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910722NA · recruiting Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06125769NA · recruiting LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05849480Phase 1/Phase 2 · recruiting A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05240040withdrawn Treat Primary and Metastatic Liver Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06140134recruiting Liver Transplantation in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411133Phase 1 · completed Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06648057recruiting Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479264completed A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06474091enrolling by invitation Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301778Phase 2 · completed Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381648completed Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224737completed Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma. · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225452completed An Exosomal miRNA-based Liquid Biopsy for ICC Detection · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04507503approved for marketing Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792463recruiting Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06859684Phase 2 · recruiting Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05346484Phase 1 · terminated A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454486not yet recruiting TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238715Phase 2 · completed A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526106Phase 1/Phase 2 · completed REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432568Phase 2 · not yet recruiting A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04233567Phase 2 · completed Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430738Phase 2 · active not recruiting Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06178588Phase 2 · active not recruiting Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped CURATED_BROADER · 883 trials mapped (290 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02073994Phase 1 · completed Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03445585recruiting Biobank for Cholestatic Liver Diseases. · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04753996recruiting Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05430698Phase 2 · recruiting PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223307Phase 2 · recruiting REGULUS: MRI-guided Adaptive SABR for Liver Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03693807Phase 2 · completed A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04459273Phase 1 · active not recruiting Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489250terminated The PLATON Network · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201519Phase 2 · recruiting Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy · condition mapped PROBABILISTIC · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06313203Phase 2 · recruiting HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290856terminated Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06739252Phase 2 · terminated Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA · condition mapped ONTOLOGY_EXACT · 883 trials mapped (290 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05993429completed Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma · condition mapped ALIAS · 883 trials mapped (290 active) | — | — | Hilar Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |